Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer

NCT02764086 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT02764086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02764086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
Lead sponsor
Cancer Trials Ireland
Phase
Phase 1/2
Overall status
Terminated
Start date
August 10, 2016
Completion date
June 5, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer